» Articles » PMID: 25117779

Molecular Basis and Genetic Predisposition to Intracranial Aneurysm

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2014 Aug 14
PMID 25117779
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Intracranial aneurysms, also called cerebral aneurysms, are dilatations in the arteries that supply blood to the brain. Rupture of an intracranial aneurysm leads to a subarachnoid hemorrhage, which is fatal in about 50% of the cases. Intracranial aneurysms can be repaired surgically or endovascularly, or by combining these two treatment modalities. They are relatively common with an estimated prevalence of unruptured aneurysms of 2%-6% in the adult population, and are considered a complex disease with both genetic and environmental risk factors. Known risk factors include smoking, hypertension, increasing age, and positive family history for intracranial aneurysms. Identifying the molecular mechanisms underlying the pathogenesis of intracranial aneurysms is complex. Genome-wide approaches such as DNA linkage and genetic association studies, as well as microarray-based mRNA expression studies, provide unbiased approaches to identify genetic risk factors and dissecting the molecular pathobiology of intracranial aneurysms. The ultimate goal of these studies is to use the information in clinical practice to predict an individual's risk for developing an aneurysm or monitor its growth or rupture risk. Another important goal is to design new therapies based on the information on mechanisms of disease processes to prevent the development or halt the progression of intracranial aneurysms.

Citing Articles

Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

Balkrishna A, Mishra S, Rana M, Rajput S, Pathak S, Liu K Front Pharmacol. 2024; 15:1469211.

PMID: 39575394 PMC: 11578703. DOI: 10.3389/fphar.2024.1469211.


Intracranial Aneurysms and Genetics: An Extensive Overview of Genomic Variations, Underlying Molecular Dynamics, Inflammatory Indicators, and Forward-Looking Insights.

Toader C, Eva L, Bratu B, Covache-Busuioc R, Costin H, Dumitrascu D Brain Sci. 2023; 13(10).

PMID: 37891822 PMC: 10605587. DOI: 10.3390/brainsci13101454.


Animal Welfare Aspects in Planning and Conducting Experiments on Rodent Models of Subarachnoid Hemorrhage.

Becker K Cell Mol Neurobiol. 2023; 43(8):3965-3981.

PMID: 37861870 PMC: 11407738. DOI: 10.1007/s10571-023-01418-5.


Dysregulated Genes and Signaling Pathways in the Formation and Rupture of Intracranial Aneurysm.

Kumar M, Patel K, Chinnapparaj S, Sharma T, Aggarwal A, Singla N Transl Stroke Res. 2023; 15(5):865-879.

PMID: 37644376 DOI: 10.1007/s12975-023-01178-w.


Mood swings are causally associated with intracranial aneurysm subarachnoid hemorrhage: A Mendelian randomization study.

Peng K, Li Y, Adegboro A, Wanggou S, Li X Brain Behav. 2023; 13(11):e3233.

PMID: 37632147 PMC: 10636415. DOI: 10.1002/brb3.3233.


References
1.
Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E . Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke. 2003; 34(6):1370-4. DOI: 10.1161/01.STR.0000072822.35605.8B. View

2.
Manolio T . Bringing genome-wide association findings into clinical use. Nat Rev Genet. 2013; 14(8):549-58. DOI: 10.1038/nrg3523. View

3.
Marchese E, Vignati A, Albanese A, Nucci C, Sabatino G, Tirpakova B . Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. J Biol Regul Homeost Agents. 2010; 24(2):185-95. View

4.
Roder C, Kasuya H, Harati A, Tatagiba M, Inoue I, Krischek B . Meta-analysis of microarray gene expression studies on intracranial aneurysms. Neuroscience. 2011; 201:105-13. DOI: 10.1016/j.neuroscience.2011.10.033. View

5.
Schievink W . Genetics and aneurysm formation. Neurosurg Clin N Am. 1998; 9(3):485-95. View